MD
Matthew David Wolf
About Matthew David Wolf
Data last updated:
Matthew David Wolf is a Director at Contract Pharmacal Corporation India Private Limited (since 2013). The company operates in Pharma. Contract Pharmacal Corporation India Private Limited reported revenue of ₹10.47 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Jun 2013 | 2013 | ₹10.47 Cr (FY 2024) | Active |
Board colleagues of Matthew David Wolf
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ketan Babulal Dalki | 09572318 | Contract Pharmacal Corporation India Private Limited | Additional Director |
| Mark Nathan Wolf | 06536610 | Contract Pharmacal Corporation India Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Matthew David Wolf
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Matthew David Wolf
Matthew David Wolf currently holds 1 directorship: Contract Pharmacal Corporation India Private Limited (Director, since 24 Jun 2013, revenue ₹10.47 Cr (FY 2024)).
Matthew David Wolf was first appointed on 24 Jun 2013 as Director at Contract Pharmacal Corporation India Private Limited.
The current boards of Matthew David Wolf's companies include Ketan Babulal Dalki (Contract Pharmacal Corporation India Private Limited), Mark Nathan Wolf (Contract Pharmacal Corporation India Private Limited).